Topic: Margaret Steger

Health experts are pushing for increased HPV vaccination rates among 11 and 12-year-olds, claiming the vaccine is most effective before any sexual exposure. A report on NPR suggested the vaccine prevents "cancer of the penis," though critics point out that the primary medical focus has traditionally been on cervical and throat cancers. The aggressive marketing of the vaccine to young children is viewed by some as an effort to reestablish medical authority over parental concerns.